Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNK-AIS multicenter registry of intravenous tenecteplase in acute ischemic stroke
ChiCTR2500102308Phase 4Recruiting
- Sponsor
- Beijing Daxing District People's Hospital
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenecteplase in ischemic stroke, sponsored by Beijing Daxing District People's Hospital. Primary endpoints: Proportion of patients with 90-day modified Rankin Scale (mRS) score 0-1 and Door-to-needle time (DNT). Started May 2025; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2500102308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102308.